| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $247.0M | -4.3% |
| R&D Expense | $523.0M | +16.7% |
| SG&A Expense | $110.0M | -8.3% |
| Operating Income | -$386.0M | -17.0% |
| Interest Expense | $9.0M | +350.0% |
| Pre-tax Income | -$353.0M | -25.2% |
| Income Tax | $0 | -100.0% |
| Net Income | -$353.0M | -24.7% |
| EPS (Basic) | -$3.29 |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222.0M | +48.0% |
| Current Assets | $1.01B | -0.9% |
| Total Assets | $1.14B | -1.0% |
| Current Liabilities | $231.0M | +2.2% |
| Long-term Debt | $99.0M | +106.3% |
| Stockholders' Equity | $631.0M | +30.1% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$482.0M | -183.5% |
| Capital Expenditures | $2.0M | -66.7% |
| Investing Cash Flow | $66.0M | +178.6% |
| Financing Cash Flow | $488.0M | +76.2% |
| Free Cash Flow | -$484.0M | -175.0% |
| -4.8% |
| EPS (Diluted) | -$3.29 | -4.8% |